As a matter of fact I think the Auditors need
to run a fine tooth comb through some of
Maynes dealings. I mean $40 million in sales
commission for the deal . Then $13.5 million
min foreign exchange losses . These numbers
are seriously high considering the size of
Mayne Pharma. I would hate to think a director
or two wasn’t just using and running the company
mad a personal Cashcow , being paid to do so
and No Risk It wouldn’t be the first time it’s
going on in many many ASX companies.
Ann: Update on convertible note arrangements with Rubric Capital, page-11
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$5.00 |
Change
0.080(1.63%) |
Mkt cap ! $406.2M | |||
| Open | High | Low | Value | Volume |
| $4.93 | $5.10 | $4.93 | $3.062M | 610.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 67102 | $5.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.05 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 24/06/2025 (20 minute delay) ? |
| MYX (ASX) Chart |